Valneva SE
VALN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001836564
No open-market purchases or sales by Valneva SE insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $19.8M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Valneva SE changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 9 | 8 | −1 |
| Shares | 800.9K | 263.4K | −537.5K (−67.1%) |
| Value | $21.1M | $8.27M | −$12.8M (−60.8%) |
New holders (5)
Institutions that held Valneva SE at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Granite Point Capital Management, L.P. | 11,982 | $376.0K | 0.15% |
| Morgan Stanley | 3,090 | $97.0K | 0.00% |
| UBS Group AG | 395 | $12.0K | 0.00% |
| Federation des caisses Desjardins du Quebec | 200 | $6.28K | 0.00% |
| Wells Fargo & Company | 100 | $3.00K | 0.00% |
Sold out (6)
Institutions that held Valneva SE at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Citadel Advisors LLC | 195,000 | $5.14M |
| General American Investors Co Inc | 75,000 | $1.98M |
| CVI Holdings, LLC | 56,395 | $1.49M |
| Millennium Management LLC | 9,823 | $259.0K |
| Symmetry Peak Management LLC | 8,109 | $214.0K |
| Tudor Investment Corp Et Al | 7,700 | $203.0K |